What some people may have forgotten is that we have already been...

What some people may have forgotten is that we have already been made an offer for 1103 back just before the start of the phase 2 trial.

"... had in parallel also been in discussions with third parties with respect to a development and commercialisation agreement and had received a licensing proposal from one of the companies. ANP advises that further discussions with the international pharmaceutical company on licensing of the ATL1103 will not proceed ahead of the Phase II clinical trial."

Did ANP put it on ice because it was lowball?
Did the pharma want to see final results before signing on the dotted line?
Multiple pharmas are also confirmed to be still looking at us now. Probably more of them than before?

I've got no doubts a deal will be done if this small bolt-on shows dose / weight correlation and good safety. Both of these look a very good chance to me, so much more than our current 10 cents.

One has been nibbling but how many of the other pharmas will try to bite?